Glenmark Pharmaceuticals has initiated voluntary recall of a skin ointment from the US after the drug exceeded the permissible impurity level. The recall is classified under the US FDA’s Class III recall, which means the use of the medicine by consumers is not likely to cause harmful reactions.The company’s US arm Glenmark Generics started recalling a total of 16,968 tubes of alclometasone dipropionate ointment in three dosage 15g, 45g and 60g as per a notification in the US Food and Drug Administration’s website. The drug is made at the company’s Indian plant at Baddi in Himachal Pradesh and expires between October 2010 and March next year. In August 2009, the New Jersey-based Glenmark Generics had launched the generic version of GlaxoSmithKline’s Aclovate, used to treat inflammatory and eruptions in skins. The company started withdrawing its cream after informing the American drug regulator in December last year.